Literature DB >> 1118565

Angiography vs. pancreatography in diagnosis of carcinoma of the pancreas.

M E Clouse, J A Gregg, C E Sedgwick.   

Abstract

Relative efficacy of angiography and pancreatography in the diagnosis of pancreatic carcinoma was assessed in 13 patients. Pancreatography provided a correct preoperative diagnosis in 10 patients. In 3 patients the duct could not be cannulated. Twelve patients underwent angiography and a correct diagnosis was made in 10. Preoperative diagnosis was not made by either technique in 1 patient. Pancreatography did not detect carcinoma of the pancreas at an earlier stage than did angiography. These procedures should be considered complementary to each other. Angiography defines the size, extension and resectability of the tumor. Pancreatography outlines the internal architecture of the gland and duct system.

Entities:  

Mesh:

Year:  1975        PMID: 1118565     DOI: 10.1148/114.3.605

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

Review 1.  ERCP.

Authors:  P B Cotton
Journal:  Gut       Date:  1977-04       Impact factor: 23.059

Review 2.  Progress report. Cancer of the pancreas.

Authors:  R G Morgan; K G Wormsley
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

3.  Endoscopic retrograde cholangiopancreatography. A review of the rewards and indications.

Authors:  P L Szego; L A Stein
Journal:  Gastrointest Radiol       Date:  1978-08-31

4.  Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage.

Authors:  V Savarino; C Mansi; L Bistolfi; P Zentilin; G Celle
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

Review 5.  A study of 122 cases of pancreatic cancer diagnosed by endoscopic retrograde cholangiopancreatography (ERCP).

Authors:  Y M Moon; W H Kim; S T Shin; C Y Chon; S I Lee; J K Kang; I S Park; H J Choi
Journal:  Korean J Intern Med       Date:  1986-07       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.